Researchers from Merck and Agilent Technologies have developed a simple and fast generic gas chromatography–flame ionization detection (GC–FID) method for the quantitation of volatile amines in pharmaceutical drugs and synthetic intermediates.
Researchers from Merck and Agilent Technologies have developed a simple and fast generic gas chromatography–flame ionization detection (GC–FID) method for the quantitation of volatile amines in pharmaceutical drugs and synthetic intermediates (1).
Among the most frequently used compounds in pharmaceutical chemistry, volatile amines offer chemists the ability to control the pH of reaction mixtures and improve product yield because of their basic properties and low boiling point. However, the selection of the “optimal” amine for a particular production also becomes a bottleneck in synthetic route development process. Many hours are devoted to the development of new analytical methods for the quantitation of residual amine content prior to each analysis session. Hours and resources that could be focused elsewhere if an alternative option existed.
This issue has been well documented with a wide spectrum of extraction procedures already existing for each separation technique. However, most require detailed sample preparation and specific instrumentation so do not address the time issue they were intended to solve. Furthermore, many of the procedures were specific and focused on a narrow group of amines, lacking the potential to be used universally. The added speed with which chemists can generate accurate and quality data with generic or more universal chromatographic methods has led to their popularity in recent years and the need for such procedures in the production of pharmaceuticals.
The method developed by researchers analyzes over 25 volatile amines and other basic polar species in a single 16-min chromatographic run using conventional and readily available GC–FID instrumentation and using either He or H2 as a carrier gas.
The validation experiments performed showed excellent sensitivity, precision, linear correlation, and accuracy for all the amines. Researchers also believe the method can be used as an effective starting point for solving challenging separations and analysis of volatile polar species beyond the list of amines described in the study.
Reference
1. G.C. Graffius et al., J. Chromatogr. A1518, 70–77 (2017).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
RP-HPLC to Compare Genotoxic Impurities in Extracted and Synthetic Nicotine
November 7th 2024A recent study examined the impurity profile of thirteen different lots of synthetic nicotine and compared them to fourteen lots of nicotine extracted from plants using in-house analytical methods, with samples tested for alkaloids and phenols with reversed-phase high-performance liquid chromatography (RP-HPLC).